Cargando…
Vesiculin derived from IGF-II drives increased islet cell mass in a mouse model of pre-diabetes
Pancreatic islet-cell function and volume are both key determinants of the maintenance of metabolic health. Insulin resistance and islet-cell dysfunction often occur in the earlier stages of type 2 diabetes (T2D) progression. The ability of the islet cells to respond to insulin resistance by increas...
Autores principales: | Lee, Kate L., Aitken, Jacqueline F., Li, Xun, Montgomery, Kirsten, Hsu, Huai-L., Williams, Geoffrey M., Brimble, Margaret A., Cooper, Garth J.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632304/ https://www.ncbi.nlm.nih.gov/pubmed/34632959 http://dx.doi.org/10.1080/19382014.2021.1982326 |
Ejemplares similares
-
Tetracycline Treatment Retards the Onset and Slows the Progression of Diabetes in Human Amylin/Islet Amyloid Polypeptide Transgenic Mice
por: Aitken, Jacqueline F., et al.
Publicado: (2010) -
Spontaneous Diabetes in Hemizygous Human Amylin Transgenic Mice That Developed Neither Islet Amyloid nor Peripheral Insulin Resistance
por: Wong, Winifred P.S., et al.
Publicado: (2008) -
Improving Islet Engraftment by Gene Therapy
por: Wang, Xiaojie, et al.
Publicado: (2011) -
Characterization of pre-transplant psychosocial burden in an integrated national islet transplant program
por: Liew, Aaron YL, et al.
Publicado: (2020) -
Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice
por: Rezania, Alireza, et al.
Publicado: (2012)